Lv31
258 积分 2021-02-28 加入
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
5小时前
求助中
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
5小时前
求助中
Danicopan: First Approval
20天前
已完结
玻璃体切割手术后联合视网膜下或玻璃体腔注射康柏西普治疗难治性糖尿病黄斑水肿的疗效对比观察
1个月前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
5个月前
已关闭
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
5个月前
已关闭
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
5个月前
已关闭
构建和验证急诊患者急性肾损伤的风险预测模型
5个月前
已完结
血清学指标联合序贯器官衰竭评估评分对重症急性肾损伤患者预后的预测价值
5个月前
已完结
皖公网安备34019202002308
